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Abstract 
 
This was a case of a young lady presenting with 10 year history of a mass in the right eye. It was found to be an 
adenocarcinoma of the lacrimal gland from histopathological biopsy. She underwent wide excision, orbital 
exenteration and reconstruction with a free rectus abdominis flap. Unfortunately, she had a tumour recurrence which 
was not controlled by radiotherapy and a second excision.  The behavior of the tumour was aggressive, resulting in 
widespread metastases. She passed away within a year of her presentation. Of note, the histopathology report from 
the second excision turned out to be sarcomatoid carcinoma. This is described in the literature as dedifferentiation, or 
high grade transformation (HGT). Occurrence of dedifferentiation in salivary gland tumours is well-established, but 
not as well-described in lacrimal gland tumours. In this case, there was a severely delayed presentation of a lacrimal 
gland adenocarcinoma in a young person, which underwent dedifferentiation into a sarcomatoid carcinoma. This 
phenomena is associated with aggressive tumour biology behavior and poor prognosis, despite surgery and 
radiotherapy. 
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Introduction 
 
There is an old English proverb, “the eyes are the 
windows to the soul”. Thus, any disease of the eye is 
distressing, as it not only impairs vision but also 
disfigures the patient. 
 
Our patient was a 33-year-old female who presented 
with a right orbital mass for a decade. 
Histopathological biopsy returned as adenocarcinoma 
of the lacrimal gland. She subsequently had wide 
excision of the tumour, orbital exentration and 
reconstruction with a free rectus abdominis flap. The 
tumour unfortunately recurred a soon after and was 
unresponsive to further oncological management. She 
passed away a few months later. The histopathology 
from the excision of recurrent tumour returned as a 
sarcomatoid carcinoma. It shows the malignancy had 
undergone dedifferentiation, or high grade 
transformation (HGT), with a poorer prognosis. 
Despite her late presentation, we decided on 
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aggressive intervention as she was young. The present 
rare case is being discussed.  
 
Lacrimal adenocarcinoma commonly occurs in middle 
age, with a multitude of symptoms ranging from visual 
disturbances, to mechanical disruption and pain. 
Although slow-growing, there is a 4-36% chance of 
neural, bony and/or intracranial extension. Metastases 
and recurrence account for poor prognosis (1).  
 
Dedifferentiated sarcomatoid carcinoma has been 
reported in the palate, facial sinuses and salivary 
glands. However, dedifferentiation in the lacrimal 
gland has not been widely reported in the literature, 
therefore the clinical course is relatively unknown. It is 
known that dedifferentiated tumours that have been 
reported show aggressive behaviour with poor 
outcomes. This highlights the importance of 
meticulous sampling and histological examination of 
orbital tumours with pathology similar to salivary 
gland malignancies, and its subsequent clinical 
implications
 
(2). 
 
Case Report 
 
We present a 33-year-old female who complained of a 
10 year history of a gradually enlarging right orbital 
mass. It was painless but associated with gradual 
blurring of vision.  
 
Upon formal examination by the ophthalmology team 
at initial presentation, the right eye was totally blind 
with no light perception and a WHO blindness score of 
5, with non-axial proptosis and complete 
ophthalmoplegia. The ocular surface was dry, but 
otherwise, anterior chamber examination was normal.  
Fundoscopy revealed pale optic disc with presence of 
macular striation. The left eye was normal (Fig. 1). 
Magnetic resonance imaging (MRI) revealed a large 
lacrimal gland mass extending to the optic canal with 
involvement of adjacent bones, paranasal sinuses and 
intracranial extension. Radical exenteration and 
craniectomy was performed, by a multidisciplinary 
team. A rectus abdominis muscle free flap with 
anastomosis to the superficial temporal vessels was 
used to cover the defect (Fig. 2). 
 
Patient was fairly well after surgery however noted a 
painless swelling over the right side of her forehead 6 
months post operatively. A repeat MRI was performed 
and was suggestive of tumour recurrence.  Patient then 
underwent a course of radiotherapy 66Gy/33#, 
completed on 16/1/2014. 
 
Despite this, the tumour progressed and was re-
excised. Intra operatively tumour had encroached the 
frontal region and into the overlying flap. Post 
operatively she had a stormy recovery complicated 
with pneumonia. 
 
The histopathology of the second excision showed 
malignant cells extensively infiltrating the stroma 
forming sheets and crowded nests. Bone infiltration 
was also seen. When compared to the previous biopsy 
it appeared similar in morphology however with 
marked sarcomatous changes. 
 
Eight months later, MRI and computed topography 
imaging revealed distant metastases to the bones, 
brain, adrenal glands and lungs.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: a) Pre-operation b) Post-operation with successful 
free-flap 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2:  a) Rectus abdominis musculocutaneous flap and 
deep inferior epigastric vessels b) Bone and soft tissue 
orbital defect post-excision of tumour 
a) b) 
a) b) 
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Her general condition gradually deteriorated and she 
was managed palliatively. Patient eventually passed 
away 15 months after her initial presentation.  
 
Discussion 
 
Timing of presentation possibly played a significant 
role in the outcome. She had sought medical attention 
almost 10 years from the onset of symptoms. The 
apparent reason she delayed her presentation was, 
focusing on marriage and having children. It was on 
the insistence of her family coupled with the loss of 
vision that she eventually sought consultation. 
 
In reported cases, the timing of presentation was 
within months of the onset of symptoms. In this case, 
the delayed presentation of a decade no doubt 
exacerbated the poor prognosis. The clinical outcome 
was affected by 3 factors. Firstly the delay in 
presentation due to patient’s own fixed mindset and 
refusal for medical attention, secondly the 
histopathological of polymorphous adenocarcinoma, 
and finally the dedifferentiation or HGT. This would 
have given the aggressive biological nature of the 
process plenty of time to infiltrate and dedifferentiate 
(1). 
 
Adenocarcinoma of the lacrimal gland is the most 
common malignant epithelial tumor of the lacrimal 
gland, it is however a rare disease. It is notorious slow 
growing and frequently recurs despite therapy. 
Approximately 10% of space occupying lesions of the 
orbits arise from the lacrimal gland. Twenty percent of 
these masses are epithelial in origin and around 55% 
of masses of epithelial origin are malignant (3). 
 
Overall the most common tumour type is lymphoma 
both within and outside the lacrimal gland (67%) 
followed by rhabdomyosarcoma (12%) followed by 
adenocarcinoma 6% and adenocystic carcinoma 5% 
the remainder include melanomas and metastatic 
disease (4). 
 
There is no general consensus on how to manage this 
disease. An aggressive approach, that includes orbital 
exenteration followed by local radiotherapy, is 
recommended Aggressive management including 
orbital exenteration and radiotherapy has 
recommended by some others, however there is debate 
in the literature as to the gold standard (5). There is 
however no apparent difference in median survival 
rate when compared to a more conservative approach
 
(6). Radiation therapy may be an adjuvant in the 
management of extensive or recurrent 
adenocarcinomas even following complete excision. 
On the other hand, it could be argued that radiation 
therapy is of little value as a salvage procedure for 
recurrent or residual tumours.  Although irradiation 
can provide short-term palliation, it apparently 
achieves little in the long-term (7). Chemotherapy may 
occasionally be clinically efficacious for the 
recurrence of adenocarcinoma. The role of radiation 
therapy in management of adenocarcinoma is 
debatable, be it in recurrent or aggressive tumours. It 
may have an adjuvant role with short-term palliative 
benefit, yet may have limited capacity in long-term 
control (7). 
 
A point to note in the repeat excision, the 
histopathology was sarcomatoid carcinoma. Such a 
difference could be attributed to either 
dedifferentiation of the carcinoma.  Dedifferentiation 
is a well-established phenomenon in salivary gland 
tumors that is associated with aggressive behavior and 
poor prognosis. However, its exact nature remains 
unclear (6). 
 
The exact transformation method in dediffentiation in 
lacrimal gland tumours has not been fully established
 
(2). Although reported literature on this phenomena is 
scarce, salivary gland tumours have been associated 
with dedifferentiation or high-grade transformation 
(HGT). Aggressive clinical progression and guarded 
prognosis ensues regardless of the histopathological 
features of the initial tumour.  Links with p53 
abnormalities in the HGT lesion has been shown in 
few cases, however the exact pathway from a 
molecular and genetic point of view is yet to be 
explored
 
(8)  
 
Conclusion 
 
The recommended management of lacrimal gland 
carcinoma, with or without HGT, is wide excision of 
the initial tumour with clear surgical margins. If the 
margins are involved with intracranial extension, 
radiotherapy and chemotherapy may be considered. 
Complex tumours benefit from multidisciplinary 
management. This is especially true in retro-orbital 
tumours. This case was surgically managed by the 
neuro, ophthalmic and plastic surgeons working 
together with extensive preoperative planning 
discussions and family meetings, working towards a 
common goal for successful excision and 
reconstruction. As clinicians, awareness and high 
index of suspicion for HGT tumours may help in 
establishing the challenging diagnosis of such cases. 
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